(Q43091623)
Statements
1 reference
Beyond HER2 and trastuzumab: heterogeneity, systems biology, and cancer origin research may guide the future for personalized treatment of very early but aggressive breast cancer (English)
1 reference
1 reference
20 April 2010
1 reference
1 reference
28
1 reference
17
1 reference
e279-80; author reply e282-3
1 reference
Identifiers
1 reference
1 reference